E. Shelley Hwang

Impact of adjuvant trastuzumab on locoregional failure rates in a randomized clinical trial: North Central Cancer Treatment Group N9831 (alliance) study

E. Perez, S. Martino, T. Pisansky, 2020, Cancer.

“Is it cancer or not?” A qualitative exploration of survivor concerns surrounding the diagnosis and treatment of ductal carcinoma in situ

E. Hwang, J. Gierisch, D. Collyar, 2022, Cancer.

Patient‐reported causes of distress predict disparities in time to evaluation and time to treatment after breast cancer diagnosis

T. Hyslop, E. S. Hwang, Ilona Stashko, 2020, Cancer.

Patterns of breast magnetic resonance imaging use: an opportunity for data-driven resource allocation.

I. Bedrosian, E. Hwang, E. Shelley Hwang, 2014, JAMA internal medicine.